Literature DB >> 21861183

Mechanisms of NK cell activation: CD4(+) T cells enter the scene.

Franck Bihl1, Claire Germain, Carmelo Luci, Veronique M Braud.   

Abstract

Natural killer (NK) cells are innate lymphocytes involved in immunosurveillance through their cytotoxic activity and their capacity to secrete inflammatory cytokines. NK cell activation is necessary to initiate effector functions and results from a complex series of molecular and cellular events. We review here the signals that trigger NK cells and discuss recent findings showing that, besides antigen-presenting cells, T cells can play a central role in the initiation of NK cell activation in lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861183     DOI: 10.1007/s00018-011-0796-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  178 in total

1.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

Authors:  T A Fehniger; M H Shah; M J Turner; J B VanDeusen; S P Whitman; M A Cooper; K Suzuki; M Wechser; F Goodsaid; M A Caligiuri
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

Review 3.  Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens.

Authors:  Kirsty C Newman; Eleanor M Riley
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

Review 4.  NK receptor interactions with MHC class I molecules in pregnancy.

Authors:  John Trowsdale; Ashley Moffett
Journal:  Semin Immunol       Date:  2008-07-24       Impact factor: 11.130

5.  Signal transduction during natural killer cell activation.

Authors:  C C Chini; P J Leibson
Journal:  Curr Protoc Cytom       Date:  2001-05

6.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

7.  Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.

Authors:  N C Fernandez; A Lozier; C Flament; P Ricciardi-Castagnoli; D Bellet; M Suter; M Perricaudet; T Tursz; E Maraskovsky; L Zitvogel
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

8.  NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1.

Authors:  Claudia Semino; Giovanna Angelini; Alessandro Poggi; Anna Rubartelli
Journal:  Blood       Date:  2005-03-31       Impact factor: 22.113

9.  APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.

Authors:  Kerstin N Schmidt; Beatrice Leung; Mandy Kwong; Kol A Zarember; Sanjeev Satyal; Tony A Navas; Fay Wang; Paul J Godowski
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

Review 10.  Natural killer cells as an initial defense against pathogens.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2006-06-12       Impact factor: 7.486

View more
  15 in total

Review 1.  The opposing roles of CD4+ T cells in anti-tumour immunity.

Authors:  Tomasz Ahrends; Jannie Borst
Journal:  Immunology       Date:  2018-04-27       Impact factor: 7.397

2.  Co-stimulation of the fc receptor and interleukin-12 receptor on human natural killer cells leads to increased expression of cd25.

Authors:  Megan C Duggan; Amanda R Campbell; Elizabeth L McMichael; Kallan S Opheim; Kala M Levine; Neela Bhave; Michelle C Culbertson; Tiffany Noel; Lianbo Yu; W E Carson
Journal:  Oncoimmunology       Date:  2017-10-16       Impact factor: 8.110

3.  A CD4+ T Cell-NK Cell Axis of Gammaherpesvirus Control.

Authors:  Clara Lawler; Philip G Stevenson
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

4.  CD4+ T Cells Control Murine Cytomegalovirus Infection Indirectly.

Authors:  Wanxiaojie Xie; Byungchul Lee; Kimberley Bruce; Clara Lawler; Helen E Farrell; Philip G Stevenson
Journal:  J Virol       Date:  2022-03-16       Impact factor: 6.549

5.  Effect of interleukin-2 level and genetic variants on coronary artery disease.

Authors:  Ru Ding; Wenwu Gao; David H Ostrodci; Zhiqing He; Yuanlin Song; Lan Ma; Chun Liang; Zonggui Wu
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

6.  Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina.

Authors:  Michelle N Kelly; Mingquan Zheng; Sanbao Ruan; Jay Kolls; Alain D'Souza; Judd E Shellito
Journal:  J Immunol       Date:  2012-11-30       Impact factor: 5.422

7.  Impact of brief exercise on peripheral blood NK cell gene and microRNA expression in young adults.

Authors:  Shlomit Radom-Aizik; Frank Zaldivar; Fadia Haddad; Dan M Cooper
Journal:  J Appl Physiol (1985)       Date:  2013-01-03

8.  Natural killer cell functional defects in pediatric patients with severe and recurrent herpesvirus infections.

Authors:  Bradley W Ornstein; Elaise B Hill; Theresa L Geurs; Anthony R French
Journal:  J Infect Dis       Date:  2012-11-21       Impact factor: 5.226

Review 9.  Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.

Authors:  Claire Germain; Sacha Gnjatic; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2015-02-23       Impact factor: 7.561

Review 10.  Effects of Peptide on NK cell-mediated MHC I recognition.

Authors:  Sorcha A Cassidy; Kuldeep S Cheent; Salim I Khakoo
Journal:  Front Immunol       Date:  2014-03-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.